top of page
  • Shrier I, Serner A, Wangensteen A, Steele RJ, Weir A. Measuring heterogeneity of reinjury risk assessments at the time of clearance to return to play: A feasibility study. J Sci Med Sport 2017 (In Press).
  • Shrier I. Strategic assessment of risk and risk tolerance (StARRT) framework for return to play decision making. Brit J Sports Med 49: 1311-1315 2015.
  • Shrier I, Safai, P, Charland L. Return-to-play following injury: Whose decision should it be? Br J Sport Med 48:394-401, 2014.
  • Shultz R, Bido J, Shrier I, Meeuwisse WH, Garza D, Matheson GO. Team clinician variability in return-to-play decisions. Clin J Sport Med 23:456-461, 2013.
  • Stovitz SD, Shrier I. Medical decision making and the importance of baseline risk. Brit J Gen Practice 63:795-797, 2013.
  • Matheson GO, Shultz R, Biddo J, Mitten MJ, Meeuwisse WM, Shrier I. Return to play decisions: are they the team physician’s responsibility? Clin J Sport Med 21(1): 25-30, 2011.
  • Klügl M, Shrier I, McBain K, Shultz R, Meeuwisse WH, Garza D, Matheson GO. The prevention of sport injury: An analysis of 12,000 published manuscripts. Clin J Sport Med 20(6): 407-412, 2010.
  • Creighton DW, Shrier I, Shultz R, Meeuwisse WH, Matheson GO. Return-to-play in sport: A decision-based model. Clin J Sport Med 20: 379-385, 2010.
  • Shrier I, Charland L, Mohtadi NGH, Meeuwisse WH, Matheson GO. The sociology of return-to-play decision making: a clinical perspective. Clin J Sport Med 20: 333-335, 2010.
  • Mazer B, Shrier I, Ehrmann Feldman D, Swaine B, Majnemar A, Kennedy E, Chilingaryan G.. Clinical management of musculoskeletal injuries in active children and youth. Clin J Sport Med 20: 249-255, 2010.
  • Shrier I. An approach to injuries in active people. Can Fam Phys 52: 727-731, 2006.
  • Shrier I. The usefulness of meta-analyses in treatment decisions.  J Bone Joint Surg [Am]  83A: 1274-1275, 2001 (letter).

Publications de prise de décision


bottom of page